Aim: To show the association between the expression level of hsa-miR-210 (miR-210) and tumor progression in prostate cancer (PCa). Methods: Quantitative PCR was performed to measure miR-210 on 55 subjects with different tumor stages; our results were then validated using three external datasets. ANOVA and Tukey's post hoc analysis were performed for comparative analyses between different tumor stages. Using the transcriptome data from The Cancer Genome Atlas for CaP, the gene expression analyses were performed on experimentally validated target genes of miR-210 identified in Tarbase and miRWalk datasets. Results & conclusion: miR-210 was significantly higher in N1 PCa compared with nonmetastatic PCa, whereas the metastatic tumor revealed a ...
MiRNAs play a relevant role in PC (prostate cancer) by the regulation in the expression of several p...
The molecular response of cancer cells to hypoxia is the focus of intense research. In the last deca...
Dysregulation of miRNAs has been demonstrated in several human malignancies including prostate cance...
<div><p>MicroRNAs (miRNAs) are small (∼22 nucleotide) non-coding RNAs that regulate a myriad of biol...
AbstractIntroductionRadiotherapy in combination with medical castration is the standard treatment fo...
MicroRNAs (miRNAs) are small (∼22 nucleotide) non-coding RNAs that regulate a myriad of biological p...
Introduction: Radiotherapy in combination with medical castration is the standard treatment for high...
The treatment of high-risk prostate cancer (HRPCa) is a tremendous challenge for uro-oncologists. Th...
The treatment of high-risk prostate cancer (HRPCa) is a tremendous challenge for uro-oncologists. Th...
Background: Recent evidence suggests that the prostate cancer (PCa)-specific up-regulation of certai...
Tumour hypoxia is a well-established contributor to prostate cancer progression and is also known to...
Abstract The clinicopathological implication and prospective molecular mechanisms of miRNA‐145‐5p in...
Background. The expression and mechanism of microRNA-205 (miRNA-205) in prostate cancer (PCa) and it...
Objective: MicroRNAs (miRNAs) are small noncoding regulatory RNAs (19-25 nucleotides) that play a ma...
MiRNAs play a relevant role in PC (prostate cancer) by the regulation in the expression of several p...
MiRNAs play a relevant role in PC (prostate cancer) by the regulation in the expression of several p...
The molecular response of cancer cells to hypoxia is the focus of intense research. In the last deca...
Dysregulation of miRNAs has been demonstrated in several human malignancies including prostate cance...
<div><p>MicroRNAs (miRNAs) are small (∼22 nucleotide) non-coding RNAs that regulate a myriad of biol...
AbstractIntroductionRadiotherapy in combination with medical castration is the standard treatment fo...
MicroRNAs (miRNAs) are small (∼22 nucleotide) non-coding RNAs that regulate a myriad of biological p...
Introduction: Radiotherapy in combination with medical castration is the standard treatment for high...
The treatment of high-risk prostate cancer (HRPCa) is a tremendous challenge for uro-oncologists. Th...
The treatment of high-risk prostate cancer (HRPCa) is a tremendous challenge for uro-oncologists. Th...
Background: Recent evidence suggests that the prostate cancer (PCa)-specific up-regulation of certai...
Tumour hypoxia is a well-established contributor to prostate cancer progression and is also known to...
Abstract The clinicopathological implication and prospective molecular mechanisms of miRNA‐145‐5p in...
Background. The expression and mechanism of microRNA-205 (miRNA-205) in prostate cancer (PCa) and it...
Objective: MicroRNAs (miRNAs) are small noncoding regulatory RNAs (19-25 nucleotides) that play a ma...
MiRNAs play a relevant role in PC (prostate cancer) by the regulation in the expression of several p...
MiRNAs play a relevant role in PC (prostate cancer) by the regulation in the expression of several p...
The molecular response of cancer cells to hypoxia is the focus of intense research. In the last deca...
Dysregulation of miRNAs has been demonstrated in several human malignancies including prostate cance...